Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 360.50
-8.10 (-2.20%)
At close: Oct 7, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 587.8 billion as of October 7, 2026. Its market cap has increased by 26.67% in one year.
Market Cap
587.80B
Enterprise Value
729.20B
Revenue
173.21B
Ranking
n/a
PE Ratio
121.34
Stock Price
360.50
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 587.80B, an increase of 1,194.33%. That is a compound annual growth rate of 12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 587.80B | 11.82% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 38.52B |
| Hester Biosciences | 18.21B |
| Titan Biotech | 16.18B |
| Zenotech Laboratories | 2.56B |
| CCME Global | 1.88B |
| Bharat Immunologicals & Biologicals Corporation | 353.21M |
| Transgene Biotek | 181.85M |
| Hindustan Bio Sciences | 75.34M |